Skip to main content

Table 3 Maternal TB and pregnancy outcomes by HIV status (n = 35)

From: Treatment and pregnancy outcomes of pregnant women exposed to second-line anti-tuberculosis drugs in South Africa

 

Total (n = 28)

HIV Negative (n = 8)

HIV Positive (n = 20)

p-value*

N (%)

N (%)

N (%)

 

TB treatment outcomes

 Completed

13 (46.4)

3 (37.5)

10 (50.0)

0.759

 Cured

4 (14.3)

2 (25.0)

2 (10.0)

 

Treatment failure

-

-

-

 

 LTFU

8 (28.6)

2 (25.0)

6 (30.0)

 

 Died

3 (10.7)

1 (12.5)

2 (10.0)

 
 

Total (n = 35)

HIV Negative (n = 11)

HIV positive (n = 24)

p-value

Pregnancy outcomes

N (%)

N (%)

N (%)

 

 Unknown pregnancy outcomes

15 (43.0)

6 (40.0)

9 (60.0)

 

 Known pregnancy outcomes

20 (57.0)

5 (25.0))

15 (75.0)

 

 Live birth (full term)

4 (20.0)

2 (40.0)

2 (13.3)

0.144

 Preterm birth

11 (55.0)

1 (20.0)

10 (66.7)

 

 Miscarriage

1 (5.0)

-

1 (6.7)

 

 Neonatal death

1 (5.0)

-

1 (6.7)

 

 Termination

3 (15.0)

2 (40.0)

1 (6.6)

 
  1. TB Tuberculosis, LTFU Lost to follow up
  2. P values from Chi-square or Fisher’s exact tests. Chi-squared, P < 0.05- statistically significant